SalvaRx Group plc announced consolidated earnings results for the year ended December 31, 2017. For the year, the company reported operating loss of £2,607,000 compared to £2,447,000 a year ago. Loss before tax was £2,807,000 compared to £2,476,000 a year ago. Net loss for the period attributable to equity holders of the parent was £1,744,000 or 0.05 pence per basic and diluted share compared to £2,038,000 or 0.06 pence per basic and diluted share a year ago. Net cash outflow from operating activities was £1,891,000 compared to £1,505,000 a year ago.